alpha-Spinasterol isolated from the root of Phytolacca americana and its pharmacological property on diabetic nephropathy

Planta Med. 2004 Aug;70(8):736-9. doi: 10.1055/s-2004-827204.

Abstract

Based on an inhibitory activity-guided fractionation for the high glucose-induced proliferation of glomerular mesangial cells (GMCs), chloroform extracts of the roots of Phytolacca americana were found to contain alpha-spinasterol (C (29)H (48)O), a delta (7)-sterol. This phytosterol proved to be a potent inhibitor (IC (50) = 3.9 x 10 (-12) g/mL, 9.5 pmol/L) of glomerular mesangial cell proliferation caused by high-ambient glucose (5.6 mM vs. 25 mM), and its inhibitory potency was about 1,000 times higher than that of simvastatin, an HMG-CoA reductase inhibitor used as a positive control. alpha-Spinasterol also significantly reduced the increases of serum triglycerides, renal weight and urinary protein excretion in streptozotocin-induced diabetic mice, and these were comparable to the results observed in insulin-treated diabetic mice. Therefore, the results obtained in this study suggest that alpha-spinasterol has a significant therapeutic potential to modulate the development and/or progression of diabetic nephropathy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Division
  • Diabetes Mellitus / chemically induced
  • Diabetes Mellitus / drug therapy
  • Diabetic Nephropathies / drug therapy*
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Glomerular Mesangium / cytology
  • Glomerular Mesangium / drug effects
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Phytolacca americana*
  • Phytotherapy*
  • Plant Extracts / administration & dosage
  • Plant Extracts / pharmacology*
  • Plant Extracts / therapeutic use
  • Plant Roots
  • Rats
  • Rats, Sprague-Dawley
  • Streptozocin

Substances

  • Plant Extracts
  • Streptozocin